Search for: "Mylan, Inc." Results 1 - 20 of 672
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Dec 2023, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc., with the Court vacating and remanding the District Court's claim construction for failure to consider extrinsic evidence. [read post]
6 Nov 2023, 1:15 pm by Steve Brachmann
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
6 Nov 2023, 1:15 pm by Steve Brachmann
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
2 Aug 2023, 11:05 am by Sofya Asatryan
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
The CA upheld this in Neurim v Generics UK Limited (t/a Mylan) [2022] EWCA Civ 370. [read post]
7 Dec 2022, 8:00 am by Linda C. Severin
  While there, she prosecuted many notable FCA cases including several qui tam cases against National Medicare Care, Inc. [read post]
10 Nov 2022, 1:25 pm by Mark Astarita
The Securities and Exchange Commission today announced insider trading charges against Ramkumar Rayapureddy, Chief Information Officer of pharmaceutical company Viatris Inc., which was formerly known as Mylan N.V. [read post]